Farmastock: A collaborative tool for the reuse of high-cost hospital medications in a public healthcare system.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gallego-Galisteo Myriam, Romero-Puerto Javier, López-Mancha María Teresa, Seisdedos-Elcuaz Rosa, Martínez-Bautista María José, Aguilar-Del Valle Esaú, Sierra-García Francisco, Jiménez-de Juan Carmen, Gándara-Ladrón de Guevara María José, Fernández-Martín Jesús María, Domínguez-Cantero Marcelo, Varas-Pérez Alberto, Gutiérrez-Lorenzo Marta, Muñoz-Cejudo Belén María, Cordero-Ramos Jaime, Tauste-Hernández Beatriz, Blánquez-Martínez David, Robustillo-Cortés María de Las Aguas, Reyes-Malia Miguel, Barbero-Hernández María José, Espinosa-Bosch María, Villalobos-Torres Lorenzo, Brieva-Herrero Teresa, Mora-Herrera Cristina, Urda-Romacho Joaquín, Casas-Hidalgo Inmaculada, Álvaro-Sanz Elena, Fuentes-Ibáñez María Belén, Núñez-Ortiz Carlos
Аннотация
OBJECTIVE: To describe the economic and operational impact of the Farmastock web-based tool for the inter-hospital redistribution of high-economic impact medicines nearing expiration within the Public Health System of Andalusia (SSPA), and to analyse its evolution, its behaviour by hospital type and the perception of professional users.
METHODS: A retrospective observational descriptive study was conducted on transfers registered in Farmastock between July 2019 and June 2025. Descriptive indicators (volume of transfers, cost avoided, most redistributed medicines) and comparative indicators (hospital type, province, efficiency per transfer) were analysed. An anonymous structured survey of professional users was included (Annex 1).
RESULTS: A total of 1,462 transfers were registered, avoiding €5,055,822.98 in spending and redistributing 93,741 units. The most frequently transferred ATC group was antineoplastic agents. The average value per transfer was €3,458.16. District hospitals led in volume, while specialised hospitals demonstrated greater efficiency per transfer. The tool was highly valued by users and its use expanded to 27 hospitals.
CONCLUSIONS: The descriptive findings suggest that Farmastock is a useful and well-valued tool associated with a positive trend in health system sustainability. Beyond the estimated economic impact, it has enabled the utilisation of medicines in exceptional clinical situations, such as palivizumab administration in paediatric patients. Future integration with artificial intelligence and corporate platforms could further amplify its impact.